NAMRU-6 Reagents
Closed Special Notice Posted
A newer solicitation was posted. See the latest solicitation from .
- Solicitation number
- VEID220006
- Agency
- Naval Supply Systems Command Department of the Navy, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Carlsbad, California 92008, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Naval Medical Logistics Command published a Special Notice announcing their intent to award a sole source contract to Life Technologies Corporation. The contract would provide laboratory reagents and equipment to the Naval Medical Research Unit No. 6 in Lima, Peru to support molecular diagnosis of influenza, adenovirus, respiratory syncytial virus, Zika, and SARS-CoV-2.
The purpose of the Special Notice is to fulfill the Naval Medical Research Unit No. 6's requirement for reagents and consumables to detect various viruses. Interested sources must submit capability statements by August 5th, 2022 demonstrating their ability to provide the required PCR enzymes, real-time platforms, Illumina equipment, and associated consumables. No set-aside designation was used, however, the Special Notice provides interested contractors until August 5th to submit capability statements that will be considered to determine whether to proceed with the announced sole source award to Life Technologies Corporation or conduct a competitive procurement. The total value and period of performance for the contract are not specified.
Notice text
The Naval Medical Logistics Command (NMLC) intends to award a sole source contract under the authority of FAR 13.106-1(b)(1) to Life Technologies Corporation of 5781 Van Allen WAY Carlsbad, California 92008-7321 for the delivery of the described requirement in support of the Naval Medical Research Unit No. 6 (NAMRU-6), Lima-Peru. The requirement is for reagents and consumables in support of NAMRU-6.
The Virology & Emerging Infections Department of the U.S. Naval Medical and Research Unit No. 6 (NAMRU-6) is seeking to purchase laboratory reagents and equipment to be used for molecular diagnosis of influenza virus, adenovirus, Metapneumovirus, Enterovirus, Rhinovirus, Respiratory Syncytial Virus, Mayaro, dengue, Chikungunya, Zika, and SARS-CoV-2 virus. Specifically, requirement involves PCR enzymes for reverse transcription, real-time platforms, and Illumina that are used for detection of human influenza viruses (Influenza A-matrix gene and B) and its subtypes (H3, H1pdm/SwH1N1, H1 seasonal and H5) (SOP N6-VIR-MB RV 014); sequencing full genome of influenza A using random amplification and pathogen discovery protocols in Illumina platform; detecting genetic material of Adenovirus in nasal and pharyngeal swab specimens (SOP N6-VIR-MB RV 007); detecting the genetic material of Metapneumovirus (MPV), Enterovirus, Rhinovirus and Respiratory Syncytial Virus in nasal and pharyngeal swabs specimens using a reverse transcription (N6-VIR-MB RV 006); and, amplification of the whole genome of the influenza A virus based on the amplification of full-length gene segments for SNP genotyping, gene expression analysis and genotype (N6-VIR-MB RV 001) and pathogen discovery in respiratory and serum samples collected in our surveillance protocols.
Attachments
| File | Type | Posted |
|---|---|---|
| Notice of Intent.doc | DOC document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| NAMRU-6 Reagents | Solicitation | |
| NAMRU-6 Reagents | Special Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity